Bloomberg Businessweek Podcast Summary

Episode: Government Shutdown Ripples Through Health Care Sector
Date: November 7, 2025
Hosts: Carol Massar & Tim Stenovec
Guest: Dr. Susan Blumenthal, Former Assistant U.S. Surgeon General; First Deputy Assistant Secretary for Women’s Health

Episode Overview

This episode of Bloomberg Businessweek delves into how the recent U.S. Government shutdown is impacting the health care sector, with a spotlight on women’s health. Dr. Susan Blumenthal joins to provide frontline insights on policy, economics, research equity, and technological advances shaping the future of women's health. The discussion also covers the evolution of breast cancer detection and current innovations at the intersection of technology and women's medicine.

Key Discussion Points & Insights

1. The Government Shutdown’s Impact on Health Care

[02:12–03:57]

• Insurance Coverage at Risk:
  Dr. Blumenthal stresses the magnitude:

  “We now have the lowest rate of uninsured people in history, 8%. However, if ... the tax credits for the marketplaces are not extended, then we have 24 million people at risk of paying twice as much for their premiums. A rise of 116% and ... an estimated 4 million could go uninsured. That’s just not acceptable in the United States.” (Dr. Blumenthal, 02:32)

• Ripple Effect for Small Businesses:

  “99% of businesses in America are small businesses. ... 10 million ... have the owners and the employees rely on the Affordable Care Act premiums, these tax credits. So ... this could be a huge increase in premiums for these small businesses and ... could affect their economic well being.” (Dr. Blumenthal, 02:49)

• Policy Stakes:
  Dr. Blumenthal makes clear the shutdown is “not just about government paychecks, but about the lifeline of health care for millions.” The uncertainty affects both coverage and the health sector economy.

2. The Evolution of Women’s Health Advocacy & Research

[03:57–05:38]

• Historical Exclusion:

  “When I started, there were no women’s health reports or conferences. Women were not in the ... clinical trials.” (Dr. Blumenthal, 04:15)

• Landmark Changes in the 1990s:
  As the inaugural Deputy Assistant Secretary for Women’s Health, Dr. Blumenthal led efforts to include women and minorities in clinical trials:

  “Today at the NIH, 52% of all clinical trial participants are women. However, NIH supported studies are only 10% of all clinical trials. So we have a long way to go.” (Dr. Blumenthal, 04:34)

• Neglected Diseases:
  She highlights overlooked issues: autoimmune diseases (80% occur in women) and different disease profiles, like heart disease’s unique symptoms in women.

  “We need to train physicians to be sensitive to those differences and to develop treatments that may be somewhat different for them.” (Dr. Blumenthal, 05:19)

3. Breakthroughs in Breast Cancer Detection

[05:38–07:58]

• Limits of Traditional Mammography:
  Mammography, “a 40-year-old technology” in the 1990s, had significant flaws, missing 20% of cancers.

• Cross-Industry Innovation:
  Dr. Blumenthal recounts a memorable collaboration:

  “If we can see the surface of Mars with a Hubble telescope... why can’t we better detect small lesions in women’s breasts?” (Dr. Blumenthal, 06:05)
  By tapping tools from NASA, CIA, and DOD, she catalyzed advances:
  “We put our nation’s top radiologists together with their top imaging scientists. And out of that came digital mammography, ... computer assisted diagnosis, ... and 3D medical imaging.” (Dr. Blumenthal, 06:23)

• Results and Optimism:

  “We have seen a remarkable decline in death from breast cancer since 1990 of 44%. ... With the 21st century tools like AI ... I'm very hopeful that we will bring those death rates down even more.” (Dr. Blumenthal, 07:35)
  Early detection boosts five-year survival to 95%.

4. Current & Future Innovations in Women’s Health

[07:58–08:40]

• Technology Advancements:
  At MIT Media Lab, Dr. Blumenthal and team are working on an “ultrasound patch you can put in a bra ... remotely monitored for dense breast tissue.”

• Midlife & Menopause Research:

  “We want to look at women in midlife, looking at menopause and new interventions there to make sure that the bonus years of life we’ve gained ... are truly better years of life, productive years of life, healthy years of life.” (Dr. Blumenthal, 08:20)

Notable Quotes & Memorable Moments

• “The first wealth is health.” (Dr. Blumenthal quoting Emerson, 02:13)

• “We put our nation’s top radiologists together with their top imaging scientists. And out of that came digital mammography ... we got a peace dividend out of our national investment in defense. And I say what better investment could there be than to save the lives of women everywhere?” (Dr. Blumenthal, 06:23)

• “If you find breast cancer early, there’s a 95% five-year survival rate. So we can cure this disease.” (Dr. Blumenthal, 07:49)

Timestamps for Important Segments

• [02:12] — Dr. Blumenthal on government shutdown’s impact on health care and insurance
• [03:57] — Reflections on the evolution of women’s health research and clinical trial equity
• [05:48] — Advances in breast cancer detection and use of cross-sector technology
• [07:58] — Present and future innovations: wearable ultrasound and menopause research

Conclusion

This episode offers both a high-level and deeply human perspective on how federal policy directly affects health care access, with a special focus on women’s health. Dr. Susan Blumenthal’s firsthand experience and advocacy over decades illuminate the critical gains made—and the urgent challenges that remain—at the intersection of policy, technology, and equity.

For those interested in health policy, technological innovation, and women’s advocacy, this episode is insightful and inspiring.